CorMine

What CorMine does

CorMine is the product brand of PubGene, a Norwegian bioinformatics company founded in 2001 and headquartered in Oslo. The company operates a family of tools built on PubGene's patented text mining algorithms and a large-scale biomedical data integration and analysis pipeline. Two product lines sit on top of this core platform: Coremine Medical, a free, domain-specific search engine and social network for medical information that visualizes networks of relationships between search terms (e.g., diseases, drugs, natural medicines, treatments, and side-effects) drawn from medical literature databases; and Coremine Vitae, a personalized, physician-mediated service that matches cancer patients to global treatment options based on their individual medical profile, including biomarkers.

Technically, CorMine's offering combines natural language processing over biomedical literature with structured data analysis to produce concept relationship graphs. Concept network visualization is the user-facing differentiator, illustrating how a search term links to diseases, drugs, treatments, and adverse effects. The company's NLP methodology is patented, which provides a defensible but aging layer of technology relative to modern generative AI approaches in biomedicine.

Commercially, CorMine operates a hybrid go-to-market model. Coremine Medical is offered as a free, self-serve web service supporting product-led growth and top-of-funnel discovery by medical professionals, researchers, and lay users. Coremine Vitae runs as a high-touch, consultative oncology service requiring physician involvement, with a subscription-based, quote-priced model that is not publicly disclosed. An additional revenue lever described is platform licensing: the COREMINE platform family is positioned to be licensed to organizations building domain-specific medical information communities. No revenue figures, headcount, funding history, named enterprise customers, or active strategic transactions are disclosed in the available data, constraining visibility into commercial scale.

Name

CorMine

Legal name

PubGene

Website

https://coremine.com

Company type

Private

Founded year

2001

Operating status

Operating

Short description

CorMine, the product brand of Norway-based PubGene, operates a patented biomedical text-mining platform offering Coremine Medical, a free medical information search community, and Coremine Vitae, a personalized oncology treatment-matching service for patients and physicians.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAJAD

Bioinformatics & Multi-omics Analysis Software

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAAAMAB

Companion Diagnostic (CDx) Co-Development Services (biopharma partnerships, clinical strategy)

Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

SECONDARYHLAAAIAI

Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)

Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

• Biomedical text mining
• Cancer treatment matching
• Clinical decision support
• Medical literature search
• Biomarker analysis platform

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Coremine Vitae Subscription: Personalized cancer treatment matching service enabling patients and physicians to find optimal global treatment based on individual medical profiles including biomarkers. This appears to be a premium subscription-based service.
2. Coremine Platform Licensing: The COREMINE platform family of tools developed by PubGene may be licensed to other organizations seeking to build domain-specific information communities on top of the platform.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

Core offering

CorMine is a family of bioinformatics software products built on PubGene's patented text mining algorithms and integrated biomedical big data. The platform offers a free medical information search engine (Coremine Medical) and a personalized cancer treatment matching service based on biomarker and gene expression analysis (Coremine Vitae), with a concept network visualization that surfaces relationships between genes, drugs, diseases, and other medical concepts.

Product overview

CorMine is a family of bioinformatics tools developed by Norwegian company PubGene, consisting of a core platform (COREMINE™) that uses patented text mining algorithms and big biomedical data integration. The platform has two specialized products built on top of it: Coremine Vitae™ provides personalized cancer treatment recommendations based on individual patient medical profiles and biomarkers, while Coremine Medical™ serves as a domain-specific search engine and social network for medical information.

Differentiator

Problem solved

Functional benefit

Brands

• Coremine Vitae: Personalized service enabling patients, together with their physicians, to find the best possible global cancer treatment, based on their individual medical profile, included biomarkers.
• Coremine Medical

Products and services

• COREMINE
• Coremine Medical
• Coremine Vitae

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

Partnerships

One partnership is on record.

• PubGenecoreStrategic or Co-development PartnerPubGene is the Norwegian bioinformatics company that developed the COREMINE family of tools using its patented text mining algorithms and big biomedical data integration pipeline. CorMine operates as the product brand while PubGene functions as the parent technology company.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Direct peers

• Foundation Medicine (Roche): Foundation Medicine provides comprehensive genomic profiling of tumors to match cancer patients with targeted therapies and clinical trials. Its biomarker-to-treatment decision-support workflow directly parallels Coremine Vitae, though with FDA-cleared tests and a much larger clinical evidence base.
• Sema4 (now GeneDx): Sema4 (now part of GeneDx) combines genomic sequencing with AI-driven health intelligence to support precision-medicine decisions, including oncology. Its biomarker-based clinical insights and data-integration approach are conceptually similar to Coremine Vitae's treatment-matching service.
• Flatiron Health (Roche): Flatiron aggregates real-world oncology clinical data and EHR information to power precision-oncology decisions and research. Its combination of structured biomedical data integration and oncology-focused analytics overlaps directly with Coremine Vitae's biomarker-matching proposition.
• UpToDate (Wolters Kluwer): UpToDate is a widely used domain-specific clinical decision-support and medical-information resource for physicians. Like Coremine Medical, it serves clinicians searching for disease-drug-treatment relationships, but with a much larger content corpus and enterprise hospital licensing model.
• Tempus AI: Tempus is a precision-medicine platform combining genomic sequencing, clinical data, and AI to support personalized oncology treatment selection. Like Coremine Vitae, it matches biomarker profiles to therapeutic options, but at vastly greater scale with deep hospital-system integrations.

Emerging players

• Owkin: Owkin applies AI to biomedical research and clinical development, particularly in oncology. Its federated-learning approach to integrating biomedical data to predict treatment response mirrors Coremine's vision of AI-driven biomedical data integration for clinical insight.
• Doximity: Doximity is a professional network and information platform for physicians, combining medical news, reference content, and clinical tools. While not focused on biomarker matching, its medical-information and clinician-engagement layer is comparable to Coremine Medical's professional audience.
• PathAI: PathAI applies AI to pathology and biomarker interpretation to support precision diagnostics and treatment selection. Its biomarker-to-therapeutic-decision workflow is adjacent to Coremine Vitae's treatment-matching service, particularly in oncology subsegments.

Broad incumbents

• Elsevier (Clinical Solutions / ClinicalKey): Elsevier's Clinical Solutions (ClinicalPath, ClinicalKey) provide clinical decision support and biomedical reference content to hospitals and physicians. Like Coremine Medical, they aggregate peer-reviewed literature into structured, searchable clinical knowledge, but with established hospital-system licensing.
• Clarivate (Life Sciences & Health): Clarivate provides biomedical literature databases, citation analytics, and life-sciences informatics products. Its underlying data assets and analytics capabilities overlap with the literature-mining and biomedical-data-integration foundation of the COREMINE platform, but at much greater scale across multiple verticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CorMine